Philogen S.p.A.   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Sovicille Italy (1996)

Organization Overview

First Clinical Trial
2005
NCT01058538
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Philogen S.p.A.